Induction of specific T-cell responses in HIV infection
Data up to Jan 2025
Total Citations Per Year
Abstract
References (38)
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
1995 • 4,310 citations
Identification of a major co-receptor for primary isolates of HIV-1
1996 • 3,649 citations
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
1996 • 3,496 citations
Viral dynamics in human immunodeficiency virus type 1 infection
1995 • 3,277 citations
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
1996 • 3,189 citations
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
1995 • 2,890 citations
Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
1996 • 2,883 citations
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
1996 • 1,364 citations
The Th1–Th2 hypothesis of HIV infection: new insights
1994 • 708 citations
Molecular Cloning and Functional Expression of a New Human CC-Chemokine Receptor Gene
1996 • 701 citations
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.
1989 • 637 citations
A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease
1995 • 569 citations
A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection
1995 • 484 citations
Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals.
1990 • 443 citations
Effect of Immunization with a Common Recall Antigen on Viral Expression in Patients Infected with Human Immunodeficiency Virus Type 1
1996 • 379 citations
A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection
1991 • 248 citations
Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals
1997 • 238 citations
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection
1987 • 177 citations
Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein GP120 of human immunodeficiency virus
1990 • 112 citations
Loss of Inducible Virus in CD45RA Naive Cells After Human Immunodeficiency Virus-1 Entry Accounts for Preferential Viral Replication in CD45RO Memory Cells
1997 • 88 citations
Serum chemokine levels in patients with non-progressing HIV infection
1996 • 84 citations
Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection
1996 • 71 citations
Initial Studies on Active Immunization of HIV-Infected Subjects Using a gp120-Depleted HIV-1 Immunogen: Long-Term Follow-Up
1996 • 59 citations
Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
1992 • 54 citations
Human Immunodeficiency Virus (HIV-l) gp160-Specific Lymphocyte Proliferative Responses of Mononuclear Leukocytes from HIV-l Recombinant gp160 Vaccine Recipients
1991 • 43 citations
Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection
1991 • 43 citations
Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160.
1994 • 43 citations
HIV infection leads to differential expression of T-cell receptor Vβ genes in CD4+ and CD8+ T cells
1993 • 42 citations
Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160
1992 • 38 citations
Assessments of Plasma HIV RNA and CD4 Cell Counts after Combined Pneumovax® and Tetanus Toxoid Vaccination: No Detectable Increase in HIV Replication 6 Weeks after Immunization
1996 • 31 citations
Impaired proliferative capacity and abnormal cytokine profile of naive and memory CD4 T cells from HIV-seropositive patients
1992 • 30 citations
HIV-Specific Vaccine Therapy: Concepts, Status, and Future Directions
1992 • 28 citations
Lymphoproliferative Responses to Mitogens and HIV-1 Envelope Glycoprotein Among Volunteers Vaccinated with Recombinant gp160
1990 • 27 citations
Markedly disturbed glutathione redox status in CD45RA+CD4+ lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset
1996 • 23 citations
The influence of MT-2 tropism on the prognostic implications of the Δ32 deletion in the CCR-5 gene
1997 • 20 citations
Virology
1996 • 11 citations
Evidence for an in vivo superantigenic activity in human immunodeficiency virus-infected individuals
1996 • 10 citations
Effect of a Recombinant CD4-IgG on In Vitro T Helper Cell Function: Data from a Phase I/II Study of Patients with AIDS
1993 • 7 citations